Anesthesia Notes on Liver Diseases
Liver diseases present unique challenges in anesthesia management due to the liver’s central role in metabolism, detoxification, coagulation, and drug clearance. These conditions may include cirrhosis, hepatitis, fatty liver disease, hepatic failure, and hepatic tumors. Anesthesiologists must perform a thorough preoperative assessment, including liver function tests (LFTs), coagulation profiles, and assessment of hepatic encephalopathy and ascites.
Key considerations include:
-
Altered Drug Metabolism: Impaired hepatic function affects the metabolism of many anesthetic agents. Drugs with high hepatic extraction ratios or those metabolized extensively by the liver (e.g., benzodiazepines, opioids, and muscle relaxants) must be used cautiously or avoided.
-
Coagulopathy: Many liver disease patients have thrombocytopenia and impaired synthesis of clotting factors, increasing the risk of bleeding. Correcting coagulopathy preoperatively is often necessary.
-
Cardiopulmonary Considerations: Patients may have associated conditions such as hepatopulmonary syndrome or portopulmonary hypertension, affecting ventilation and hemodynamic stability during anesthesia.
-
Volume Management: Ascites and hypoalbuminemia complicate fluid management. Careful monitoring is required to avoid fluid overload or renal hypoperfusion.
-
Encephalopathy Risk: Hepatic encephalopathy may be exacerbated by anesthetic drugs. Avoiding sedatives that linger or worsen mental status is crucial.
In summary, anesthesia in liver disease requires a tailored approach that considers altered pharmacokinetics, coagulation status, and multisystem involvement. Close intraoperative monitoring and postoperative support are essential for optimizing patient outcomes.
This book is available at Books Hub Pk. Order now and get home delivery all over Pakistan within 3 Working days.
